期刊文献+

余江毅教授治疗亚急性甲状腺炎经验 被引量:2

Professor YU Jiangyi's Experience in Treating SAT
下载PDF
导出
摘要 [目的]总结余江毅教授治疗亚急性甲状腺炎(subacute thyroiditis,SAT)的临床经验。[方法]从SAT的病因病机、传统西医疗法与中药疗法、中西医结合疗法、中医辨证分型及SAT发病分期等方面阐述余江毅教授治疗本病的经验,并辅以临床治疗典型案例,加以说明佐证。[结果]余江毅教授在中医理论的指导下,认为本病的病因主要是情志内伤,或气血素虚、加之感受外邪或劳倦内伤,并将临床症状归纳为热毒壅盛证、气郁火旺证或气郁痰阻证和气阴两虚证四大证型。余江毅教授结合现代医学认识,提出中药配合非甾体类抗炎药的中西医结合疗法,并善用清热解毒消肿之法联合依托考昔镇痛消炎治疗SAT,临床疗效显著。[结论]余江毅教授的清热解毒消肿之方联合依托考昔疗法行之有效,急以西医治标,缓以中医治本,值得传承与推广。 [Objective]To summarize the clinical experience of Professor YU Jiangyi in the treatment of subacute thyroiditis.[Methods]This article expounds professor YU Jiangyi's experience in treating this disease from the aspects of etiology and pathogenesis of SAT, traditional western medicine therapy and traditional Chinese medicine therapy, integrated traditional Chinese and western medicine therapy, TCM syndrome differentiation,stage of SAT and so on.In order to better describe this therapy, clinical cases were reported.[Results]Under the guidance of the theory of traditional Chinese medicine, Professor YU Jiangyi thought that the cause of the disease was mainly emotional internal injury, deficiency of Qi and blood, coupled with the feeling of external evil or exerting internal injuries. And the clinical symptoms of SAT were reduced to heat warm, stagnation of Qi and fire or stagnation of Qi and phlegm obstruction and syndrome of deficiency of Qi and Yin in two. In combination with modern medical knowledge, Professor YU Jiangyi put forward the combination of traditional Chinese medicine and non-steroidal anti-inflammatory drugs. Professor YU Jiangyi used the method of clearing away heat and detoxicating, detumescence, and Etoricoxib in the treatment of SAT. In clinically, the curative effect was remarkable. [Conclusion]Professor YU Jiangyi's combination of clearing away heat and toxic swelling and Etoricoxib is effective, urgent treatment with western medicine, treating the root for slow disease with Chinese medicine, and worthy of inheritance and promotion.
作者 顾黎 余江毅
出处 《浙江中医药大学学报》 CAS 2017年第11期883-886,共4页 Journal of Zhejiang Chinese Medical University
关键词 SAT 瘿病 清热解毒消肿 中药 依托考昔 余江毅 医案 临床经验 subacute thyroiditis gall disease clearing away heat and toxic swelling traditional Chinese medicine Etoricoxib YU Jiangyi medical records clinical experience
  • 相关文献

参考文献8

二级参考文献65

  • 1潘文奎.对甲状腺机能亢进症证治矛盾的处理[J].中医药研究,1993,9(2):15-17. 被引量:15
  • 2徐润强,许荣华,肖隆斌,冯文利,陈克.增城市居民甲状腺肿大与碘营养关系的调查[J].中国地方病学杂志,2003,22(2):152-154. 被引量:5
  • 3李文兰,王艳萍,季宇彬,邹翔.中药经皮给药系统研究概况[J].中医杂志,2005,46(7):548-550. 被引量:20
  • 4申红梅.全球碘缺乏病流行现状[J].中国地方病学杂志,2005,24(5):587-589. 被引量:34
  • 5岳兴如,侯宗霞,刘萍,王澍嵩.白茅根抗炎的药理作用[J].中国临床康复,2006,10(43):85-87. 被引量:43
  • 6SHAUNTA D M, KIMI S V, TONI L ,et al. Ripley etoricoxib: a highly selective COX-2 inhibitor[J]. Ann Pharmacother,2005,39 : 854 - 862. 被引量:1
  • 7RIENDEAU M D, PERCIVAL C, BRIDEA U,et al. Etoricoxib etoricoxib ( MK-0663 ) : preelinieal profile and comparison with other agents that selectively inhibit cyclooxygenase-2[ J]. J Pharmacol Exp Ther, 2001, 296: 558. 被引量:1
  • 8JULES I,SCHWART Z, PHAR M D,et al. Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 Versus COX-I in healthy subjects [ J ]. J Clin Pharmacol , 2008,48:745-754. 被引量:1
  • 9LAINE L, CURTIS S P, LANGMAN M, et al. Lower gastrointestinal events in a double-blind trial of the cyclooxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac [ J ]. Gastroenterology, 2008, 135(5): 1517-1525. 被引量:1
  • 10BINGHAM C O, SEBBA A I, RUBIN B R, et al. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies [ J ]. Rheumatology, 2007,46 : 496 - 507. 被引量:1

共引文献58

同被引文献29

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部